Pharmaceutical drug development
The company aims to translate biomedical science knowledge into novel pharmaceutical drugs.
Source: LinkedIn company description · Retrieved October 13, 2026
Biomind is a biotechnology research and development company focused on translating biomedical science knowledge into pharmaceutical drugs and nanotechnology delivery systems.
Its stated development areas include treatments for psychiatric and neurological conditions. Its current development focus is fast-acting psychedelic molecules.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company aims to translate biomedical science knowledge into novel pharmaceutical drugs.
Source: LinkedIn company description · Retrieved October 13, 2026
The company aims to develop nanotechnology delivery systems for psychiatric and neurological conditions.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 16, 2026 and September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.